-
1 Comment
Indraprastha Medical Corporation Limited is currently in a long term uptrend where the price is trading 31.7% above its 200 day moving average.
From a valuation standpoint, the stock is 81.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Indraprastha Medical Corporation Limited's total revenue sank by 14.5% to $2B since the same quarter in the previous year.
Its net income has increased by 12.2% to $120M since the same quarter in the previous year.
Finally, its free cash flow fell by 0.0% to $56M since the same quarter in the previous year.
Based on the above factors, Indraprastha Medical Corporation Limited gets an overall score of 3/5.
ISIN | INE681B01017 |
---|---|
Sector | Healthcare |
Exchange | NSE |
CurrencyCode | INR |
Industry | Medical Care Facilities |
Market Cap | 39B |
---|---|
PE Ratio | 25.74 |
Target Price | 670 |
Dividend Yield | 1.0% |
Beta | 0.75 |
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and transplant, as well as laboratory services, internal medicine, preventive health, and sleep medicine. The company was founded in 1983 and is based in New Delhi, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for INDRAMEDCO.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025